301015 Stock Overview
Engages in research and development, production, and sale of pharmaceutical products.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 5/6 |
Past Performance | 6/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Qingdao Baheal Medical INC. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥23.39 |
52 Week High | CN¥43.50 |
52 Week Low | CN¥21.31 |
Beta | 0.35 |
11 Month Change | -0.64% |
3 Month Change | -29.93% |
1 Year Change | 4.51% |
33 Year Change | -12.07% |
5 Year Change | n/a |
Change since IPO | -58.35% |
Recent News & Updates
It's Down 25% But Qingdao Baheal Medical INC. (SZSE:301015) Could Be Riskier Than It Looks
Jun 30Qingdao Baheal Medical (SZSE:301015) Looks To Prolong Its Impressive Returns
Jun 21Qingdao Baheal Medical (SZSE:301015) Has Affirmed Its Dividend Of CN¥0.762
May 26Qingdao Baheal Medical (SZSE:301015) Has A Rock Solid Balance Sheet
May 21Recent updates
It's Down 25% But Qingdao Baheal Medical INC. (SZSE:301015) Could Be Riskier Than It Looks
Jun 30Qingdao Baheal Medical (SZSE:301015) Looks To Prolong Its Impressive Returns
Jun 21Qingdao Baheal Medical (SZSE:301015) Has Affirmed Its Dividend Of CN¥0.762
May 26Qingdao Baheal Medical (SZSE:301015) Has A Rock Solid Balance Sheet
May 21Many Would Be Envious Of Qingdao Baheal Medical's (SZSE:301015) Excellent Returns On Capital
Mar 01Shareholder Returns
301015 | CN Healthcare | CN Market | |
---|---|---|---|
7D | 8.6% | 4.7% | -0.6% |
1Y | 4.5% | -31.3% | -22.0% |
Return vs Industry: 301015 exceeded the CN Healthcare industry which returned -31.3% over the past year.
Return vs Market: 301015 exceeded the CN Market which returned -22% over the past year.
Price Volatility
301015 volatility | |
---|---|
301015 Average Weekly Movement | 4.4% |
Healthcare Industry Average Movement | 5.1% |
Market Average Movement | 5.7% |
10% most volatile stocks in CN Market | 9.0% |
10% least volatile stocks in CN Market | 3.9% |
Stable Share Price: 301015's share price has been volatile over the past 3 months.
Volatility Over Time: 301015's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 2,642 | Gang Fu | www.bahealpharma.com |
Qingdao Baheal Medical INC. engages in research and development, production, and sale of pharmaceutical products. The company offers vitamin D calcium chewable tablets.
Qingdao Baheal Medical INC. Fundamentals Summary
301015 fundamental statistics | |
---|---|
Market cap | CN¥12.29b |
Earnings (TTM) | CN¥656.31m |
Revenue (TTM) | CN¥7.56b |
18.7x
P/E Ratio1.6x
P/S RatioIs 301015 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
301015 income statement (TTM) | |
---|---|
Revenue | CN¥7.56b |
Cost of Revenue | CN¥5.30b |
Gross Profit | CN¥2.27b |
Other Expenses | CN¥1.61b |
Earnings | CN¥656.31m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 28, 2024
Earnings per share (EPS) | 1.25 |
Gross Margin | 29.98% |
Net Profit Margin | 8.68% |
Debt/Equity Ratio | 45.7% |
How did 301015 perform over the long term?
See historical performance and comparison